Hallmarks of the progression of NAFLD to NASH are inflammation and liver injury, with the release of cytokines and chemokines, such as IL-1β and tumor necrosis factor α (TNF-α) [10,11]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.